China's E-cigarette Exports to the US Surge in December 2023

Industry Insight by Mincy
Jan.23.2024
China's E-cigarette Exports to the US Surge in December 2023
China's e-cigarette exports to the US in December 2023 reached approximately $327 million, with a 22.31% monthly and 21.96% yearly increase.

According to the latest trade data released by the General Administration of Customs of the People's Republic of China, 2FIRSTS has compiled the e-cigarette export statistics from China to the United States in December 2023 as follows:

China's E-cigarette Exports to the US Surge in December 2023
Image source: 2FIRSTS (created by Mincy)

 

The export value amounted to approximately 327 million US dollars, representing a 22.31% increase compared to the previous period and a 21.96% increase compared to the same period last year.

China's E-cigarette Exports to the US Surge in December 2023
Image source: 2FIRSTS (Graphic by Mincy)

 

The export volume reached approximately 7,357 tons, with a month-on-month increase of 21.16% and a year-on-year increase of 42.79%.

China's E-cigarette Exports to the US Surge in December 2023
Image source: 2FIRSTS (Graphic by Mincy)

 

The export unit price is $44.4 per kilogram, showing a month-on-month increase of 0.95% and a year-on-year decrease of 14.59%. The average price of "e-cigarettes and similar personal electronic vaporizing devices" is $2.78 per unit.

China's E-cigarette Exports to the US Surge in December 2023
Image source: 2FIRSTS (created by Mincy)

 

Among them, "e-cigarettes and similar personal electronic vaporizing devices" accounted for 22.54% of the export product category, while "non-combustible products not containing tobacco or reconstituted tobacco, but containing nicotine for inhalation purposes" accounted for 77.46%.

China's E-cigarette Exports to the US Surge in December 2023
Image source: 2FIRSTS (Mincy Design)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ETN: Tracking Regulatory Changes in Tobacco Laws Worldwide
ETN: Tracking Regulatory Changes in Tobacco Laws Worldwide
Since 2024, global tobacco regulation has shown diverging trends: several European countries have imposed flavor bans and disposable vape restrictions; Australia’s “prescription model” faces black market challenges; North America’s stricter flavor controls have sparked market debate; while Asian nations are seeking a balance between economic interests and public health.
Jul.07 by 2FIRSTS.ai
JUUL pays $2.5 million to the U.S. state of Minnesota, with the total settlement amount reaching $60.5 million
JUUL pays $2.5 million to the U.S. state of Minnesota, with the total settlement amount reaching $60.5 million
Minnesota receives an additional $2.5 million settlement from JUUL, totaling $60.5 million for youth smoking prevention.
Aug.20 by 2FIRSTS.ai
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
After PMI released its Q2 2025 earnings, a 2Firsts reader submitted an in-depth analysis unpacking key concerns behind the headline numbers. While earnings beat expectations, slowing organic revenue growth, challenges in combustibles and ZYN, and a low margin for error under high valuation have triggered market unease. The next few quarters may prove pivotal for PMI’s growth narrative.
Jul.24
Juul Labs Files Lawsuit Against NJOY and Altria Over Patent Infringement
Juul Labs Files Lawsuit Against NJOY and Altria Over Patent Infringement
Juul Labs sues NJOY and Altria for patent infringement, escalating legal battle over e-cigarette technology.
Aug.11 by 2FIRSTS.ai
Philippines NBI Cracks Down on Illegal Vapes in July, Announces Third Enforcement Case
Philippines NBI Cracks Down on Illegal Vapes in July, Announces Third Enforcement Case
The Philippines’ National Bureau of Investigation (NBI) has intensified its crackdown on the illegal vape market, launching a series of large-scale sting operations. Since July, the NBI has dismantled illegal e-cigarette distribution networks in several regions, arrested multiple suspects, and seized unregistered vape products worth millions of pesos.
Jul.08
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai